|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1446 Duke Street |
Address2 |
|
| City | Alexandria |
State | VA |
Zip Code | 22314 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | Alexandria |
State | VA |
Zip Code | 22314 |
Country | USA |
|
5. Senate ID# 28481-12
|
||||||||
|
6. House ID# 316440000
|
||||||||
| TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Irene M. Walsh |
Date | 10/15/2024 11:58:39 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Contacts in support of retaining all current pro-life appropriations riders and maintaining funding levels of certain riders in FY25 appropriations. Contacts in support of new riders including those related regulation of chemical abortion drugs, paying for elective health abortions at Veterans Affairs, and others related to defunding the Department of Defense policy to pay for abortion-related travel. Contacts in regard to certain earmarks to facilities providing abortion.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page.
Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy.
Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital.
Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions.
Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter.
Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced).
Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable.
Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind.
Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions.
Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285.
Contacts in opposition to regulation to make abortion drugs available by telemedicine.
Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present.
Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced).
Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision.
Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion.
Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty.
Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions.
Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development.
Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking.
Contacts in regard to legislation (not introduced) to abortion operations on Federal lands.
Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases.
Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs.
Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others).
Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program.
Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024.
Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024.
Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052).
Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood.
Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic.
Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken.
Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion.
Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon.
Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal.
Contacts regarding strengthening guidance to providers against steering patients away from treatment.
Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market.
Contacts in support of H.485 to ban the use of QALYs to deny life-saving medical treatment on the basis of disability.
Contacts in support of Simon's Law requiring providers to inform at least one parent or legal guardian of a physicians intent to institute a DNR both orally and in writing and providing either parent with authority to refuse consent for a DNR.
Contacts in regards to legislation and resolutions on IVF, to the extend they might impact abortion policy. No position taken.
Contacts in opposition to the so-called Right to IVF Act (S.4445) due to a definition of assisted reproductive technology that is so expansive, it can be reasonably interpreted to impose a new right to human cloning, the genetic engineering of embryos including human-animal hybrids, or chimeras.
Contacts in opposition to the so-called "Right to Contraception Act" (S. 4381) which goes far beyond contraception (NRLC takes no position on contraception), and includes provisions related to the funding of abortion providers and contains language that could expand the use of drugs to induce an abortion weeks or months into a pregnancy.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2023 (S.3537/H.R. 6505) and similar legislation which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn.
Contacts in support of legislation (not introduced) to establish a Federal tax credit for pregnancy centers.
Contacts in regards to HR7024, the Tax Relief for Americans Act. No position taken.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Contacts in regard to September 9, 2022, Interim Final Rule RIN 2900-AR57 regarding providing for abortion for "health reasons" for VA healthcare beneficiaries.
Contacts in support of S.J.Res.10, a resolution of disapproval under the Congressional Review Act to block the Department of Veterans Affairs Interim Final Rule on Abortion.
Contacts in support of the VA Abortion Transparency Act of 2024 (H.R.8029/S.4128) to require abortion numbers from the VA.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
Contacts in opposition to DOD memorandum, Ensuring Access to Reproductive Health Care, published on October 20, 2022 which will reimburse travel expenses relating to abortion services.
Contacts in support of Van Duyne Amendment (#55) to NDAA (H.R. 8070) to defund the DOD memorandum.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Contacts in support of proposed rule, "Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation," 88 FR 12875 (March 1, 2023), (RIN): 1117-AB40, Docket ID DEA-407 due to impact of assisted suicide drugs.
Contacts regarding vending machine dispensing of chemical abortion drugs.
17. House(s) of Congress and Federal agencies Check if None
Drug Enforcement Administration (DEA), U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOR
16. Specific lobbying issues
Contacts regarding PEPFAR reauthorization over whether federal funds are going to funding recipients who also promote abortion.
Contacts regarding MOC letter urging the WHO to refrain from adding the Center for Reproductive Rights as a health organization with special status.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Contacts in opposition to proposed regulations, Regulations to Implement the Pregnant Workers Fairness Act, 88 Fed. Reg 54714 (August 11, 2023), (RIN): 3046-AB30) due to requirement that employers with 15 or more employees enable employees to obtain elective abortion, including providing paid or unpaid leave.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Equal Employment Opportunity Commission (EEOC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ACC
16. Specific lobbying issues
Contan=cts in opposition to propose regulations. Regulations to implement the Pregnant Workers Fairness Act,88 Fed. Reg 54714(August 11, 2023),(RIN):3046-AB30)due to requirement that employees with 15 or more employees enable employees to obtain elective abortion, including providing paid or unpaid leave
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
ACC |
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |